Search results for "41"

showing 10 items of 3365 documents

Treatment choices and neuropsychological symptoms of a large cohort of early MS

2018

ObjectiveTo assess clinical characteristics, distribution of disease-modifying treatments (DMTs), and neuropsychological symptoms in a large cohort of patients with early-stage MS.MethodsThe German National MS Cohort is a multicenter prospective longitudinal cohort study that has recruited DMT-naive patients with clinically isolated syndrome (CIS) and relapsing-remitting MS (RRMS) since 2010. We evaluated their baseline characteristics and the prevalence of neuropsychological symptoms.ResultsOf 1,124 patients, with a 2.2:1 female-to-male ratio and median age at onset of 31.71 years (interquartile range [IQR]: 26.06–40.33), 44.6% and 55.3% had CIS and RRMS, respectively. The median Expanded …

medicine.medical_specialty41610 Medicine & healthArticle03 medical and health sciences0302 clinical medicineQuality of lifeInterquartile rangeInternal medicinemedicineddc:610030212 general & internal medicine10. No inequalityDepression (differential diagnoses)Expanded Disability Status ScaleClinically isolated syndromebusiness.industryMultiple sclerosisNeuropsychologymedicine.disease3. Good healthNeurologyCohortNeurology (clinical)businessFunction and Dysfunction of the Nervous System030217 neurology & neurosurgery
researchProduct

The Effects of Intensive Weight Reduction on Body Composition and Serum Hormones in Female Fitness Competitors.

2017

Worries about the potential negative consequences of popular fat loss regimens for aesthetic purposes in normal weight females have been surfacing in the media. However, longitudinal studies investigating these kinds of diets are lacking. The purpose of the present study was to investigate the effects of a 4-month fat-loss diet in normal weight females competing in fitness-sport. In total 50 participants finished the study with 27 females (27.2 +/- 4.1 years) dieting for a competition and 23 (27.7 +/- 3.7 years) acting as weight-stable controls. The energy deficit of the diet group was achieved by reducing carbohydrate intake and increasing aerobic exercise while maintaining a high level of…

medicine.medical_specialtyANOREXIA-NERVOSAINCREASED PROTEIN-INTAKEENERGY DEFICITVastus lateralis musclePhysiologyAdipose tissueRESEARCH WORKING GROUP030209 endocrinology & metabolismBiologysex hormonesravinto03 medical and health sciences0302 clinical medicineWeight lossPhysiology (medical)Internal medicinemedicineBODYBUILDING CONTEST PREPARATIONAerobic exerciseTestosteronefat losskehonkoostumusOriginal Researchthyroid hormonessukupuolihormonitbody compositionexerciseLeptinLEAN MASS GAIN1184 Genetics developmental biology physiologyDIETARY-PROTEINta3141030229 sport sciencesIOC MEDICAL COMMISSIONfitnessEndocrinologyADIPOSE-TISSUEnutritionLean body mass3111 Biomedicinemedicine.symptomMETABOLIC ADAPTATIONDietingFrontiers in physiology
researchProduct

Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease

2006

Abstract Background Sphingomyelin (SM) is the major phospholipid in cell membranes and in lipoproteins. In human plasma, SM is mainly found in atherogenic lipoproteins; thus, high levels of SM may promote atherogenesis. Methods We investigated in a median follow up of 6.0 years the association of SM with the incidence of a combined endpoint (myocardial infarction and cardiovascular death) in stable and unstable patients, and its relation to other marker of atherosclerosis in 1,102 patients with angiographically documented CAD and 444 healthy controls. Results and discussion Logistic regression analysis showed that SM categorized by median was associated with an elevated risk for CAD (HR 3.2…

medicine.medical_specialtyAcute coronary syndromeApolipoprotein BEndocrinology Diabetes and MetabolismMedicine (miscellaneous)lcsh:TX341-641Clinical nutritionGastroenterologyCoronary artery diseasechemistry.chemical_compoundMedian follow-upInternal medicinemedicineMyocardial infarctionRisk factorlcsh:RC620-627Nutrition and DieteticsTriglyceridebiologybusiness.industryResearchmedicine.diseaselcsh:Nutritional diseases. Deficiency diseasesEndocrinologychemistrybiology.proteinbusinesslcsh:Nutrition. Foods and food supplyNutrition & Metabolism
researchProduct

Fear of falling and coexisting sensory difficulties as predictors of mobility decline in older women.

2012

BACKGROUND: Mobility decline, the coexistence of several sensory difficulties and fear of falling (FOF) are all common concerns in older people; however, knowledge about the combined effect of FOF and coexisting sensory difficulties on mobility is lacking. METHODS: Data on self-reported FOF, difficulties in hearing, vision, balance, and walking 2 km were gathered with a structured questionnaire among 434 women aged 63-76 years at baseline and after a 3-year follow-up. Logistic regression models were used for analyses. RESULTS: Every third participant reported difficulties in walking 2 km at baseline. In cross-sectional analysis, the odds ratio for difficulties in walking 2 km was higher amo…

medicine.medical_specialtyAgingActivities of daily livingPoison controlFear of fallingRisk AssessmentOddsCohort Studies03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationPredictive Value of TestsSurveys and QuestionnairesInjury preventionActivities of Daily LivingmedicineConfidence IntervalsOdds RatioHumans030212 general & internal medicineMobility LimitationGeriatric AssessmentPostural BalanceFinlandBalance (ability)Agedbusiness.industryAge Factorsta3141Odds ratioFearMiddle AgedPrognosisDifficulty walkingCross-Sectional StudiesLogistic ModelsSensation DisordersPhysical therapyAccidental FallsFemaleGeriatrics and Gerontologymedicine.symptombusiness030217 neurology & neurosurgeryThe journals of gerontology. Series A, Biological sciences and medical sciences
researchProduct

OGT and OGA expression in postmenopausal skeletal muscle associates with hormone replacement therapy and muscle cross-sectional area

2013

Protein glycosylation via O-linked N-acetylglucosaminylation (O-GlcNAcylation) is an important post-translational regulatory mechanism mediated by O-GlcNAc transferase (OGT) and responsive to nutrients and stress. OGT attaches an O-GlcNAc moiety to proteins, while O-GlcNAcase (OGA) catalyzes O-GlcNAc removal. In skeletal muscle of experimental animals, prolonged increase in O-GlcNAcylation associates with age and muscle atrophy. Here we examined the effects of hormone replacement therapy (HRT) and power training (PT) on muscle OGT and OGA gene expression in postmenopausal women generally prone to age-related muscle weakness. In addition, the associations of OGT and OGA gene expressions with…

medicine.medical_specialtyAgingGlycosylationTime Factorsmedicine.drug_classPlyometric ExerciseBiologyta3111N-AcetylglucosaminyltransferasesBiochemistryGene Expression Regulation EnzymologicEndocrinologyDownregulation and upregulationInternal medicineGene expressionGeneticsmedicineHumansMuscle StrengthRNA Messengerta315Muscle SkeletalMolecular BiologyFinlandGlyceraldehyde 3-phosphate dehydrogenasePlyometric power trainingEstrogen Replacement Therapyta1182Age FactorsMuscle weaknessSkeletal muscleta3141Cell BiologyMiddle Agedbeta-N-AcetylhexosaminidasesMuscle atrophyPostmenopausePhenotypeTreatment OutcomeEndocrinologymedicine.anatomical_structureEstrogenbiology.proteinFemaleMuscle atrophymedicine.symptomProtein Processing Post-TranslationalMuscle ContractionMuscle contraction
researchProduct

Endocrine Challenges in Patients with Continuous-Flow Left Ventricular Assist Devices

2021

Heart failure (HF) remains a leading cause of morbidity, hospitalization, and mortality worldwide. Advancement of mechanical circulatory support technology has led to the use of continuous-flow left ventricular assist devices (LVADs), reducing hospitalizations, and improving quality of life and outcomes in advanced HF. Recent studies have highlighted how metabolic and endocrine dysfunction may be a consequence of, or associated with, HF, and may represent a novel (still neglected) therapeutic target in the treatment of HF. On the other hand, it is not clear whether LVAD support, may impact the outcome by also improving organ perfusion as well as improving the neuro-hormonal state of the pat…

medicine.medical_specialtyAnemiamedicine.medical_treatmentheart failurelcsh:TX341-641030209 endocrinology & metabolismReview030204 cardiovascular system & hematologyEndocrine System Diseases03 medical and health sciences0302 clinical medicineQuality of lifemedicineHumansEndocrine systemTestosteroneinfectionsVitamin DIntensive care medicineCardiac RehabilitationNutrition and DieteticsRehabilitationTSHbusiness.industryTestosterone (patch)medicine.diseaseThyroid DiseasesanemiaVADErythropoietinHeart failureCirculatory systemventricular assist deviceserythropoietinHeart-Assist Devicesbusinesslcsh:Nutrition. Foods and food supplyFood Sciencemedicine.drugNutrients
researchProduct

Gait Impairment in a Rat Model of Focal Cerebral Ischemia

2012

The availability of proper tests for gait evaluation following cerebral ischemia in rats has been limited. The automated, quantitative CatWalk system, which was initially designed to measure gait in models of spinal cord injury, neuropathic pain, and peripheral nerve injury, is said to be a useful tool for the study of motor impairment in stroke animals. Here we report our experiences of using CatWalk XT with rats subjected to transient middle cerebral artery occlusion (MCAO), during their six-week followup. Large corticostriatal infarct was confirmed by MRI in all MCAO rats, which was associated with severe sensorimotor impairment. In contrast, the gait impairment was at most mild, which i…

medicine.medical_specialtyArticle Subjectbusiness.industryIschemiata3141medicine.diseaseta3112SurgeryPreferred walking speedGait (human)Gait impairmentPhysical medicine and rehabilitationPeripheral nerve injuryNeuropathic painmedicineNeurology. Diseases of the nervous systemcardiovascular diseasesNeurology (clinical)RC346-429businessSpinal cord injuryStrokeResearch ArticleStroke Research and Treatment
researchProduct

Effects of l-Carnitine in Patients with Autism Spectrum Disorders: Review of Clinical Studies

2019

Carnitine is an amino acid derivative, which plays several important roles in human physiology, in the central nervous system, and for mitochondrial metabolism, in particular. Altered carnitine metabolic routes have been associated with a subgroup of patients with autism spectrum disorders (ASD) and could add to the pathophysiology associated with these disorders. We review the current evidence about the clinical effects of carnitine administration in ASD in both non-syndromic forms and ASD associated with genetic disorders. Two randomized clinical trials and one open-label prospective trial suggest that carnitine administration could be useful for treating symptoms in non-syndromic ASD. Th…

medicine.medical_specialtyAutism Spectrum DisorderCentral nervous systemPharmaceutical ScienceReviewComorbidityAnalytical Chemistrylaw.inventionlcsh:QD241-44103 medical and health sciences0302 clinical medicineNeurodevelopmental disorderlcsh:Organic chemistryRandomized controlled triallawCarnitineInternal medicinemental disordersDrug DiscoveryIntellectual disabilitymedicineHumansgenetic disordersGenetic Predisposition to DiseaseCarnitinePhysical and Theoretical ChemistryRandomized Controlled Trials as Topic030304 developmental biology0303 health sciencesDose-Response Relationship Drugbusiness.industryOrganic Chemistryvitaminmedicine.diseaseneurodevelopmental disorderPathophysiologyClinical trialTreatment Outcomemedicine.anatomical_structureChemistry (miscellaneous)Molecular MedicineAutismnutritional supplementationbusinessmetabolism030217 neurology & neurosurgerymedicine.drugMolecules
researchProduct

Is 're-calibration' of standard cardiovascular disease (CVD) risk algorithms the panacea to improved CVD risk prediction and prevention?

2018

This editorial refers to ‘Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies’, by L. Pennells et al., doi:10.1093/eurheartj/ehy653.

medicine.medical_specialtyCalibration (statistics)Cvd riskehkäisyMEDLINEDisease030204 cardiovascular system & hematologyPanacea (medicine)03 medical and health sciencesrisk prediction0302 clinical medicinepreventioncardiovascular diseasealgoritmitMedicinerisk algorithms030212 general & internal medicineIntensive care medicineta315riskitbusiness.industryta3141ta3121ennustettavuussydän- ja versisuonitauditCardiology and Cardiovascular MedicinebusinessRisk assessmentEuropean Heart Journal
researchProduct

Aging and systemic hormonal status affects the circulating miR-21, miR-146a and FasL levels

2015

MicroRNAs are small molecules, found in all cell types and body fluids, which most commonly affect negatively to gene expressions by translational repression. Their role in various physiological conditions and diseases has been emphasized during the last twenty years. In our recent studies with postmenopausal monozygotic twin sisters (n=11), we have investigated how different systemic hormonal status affects the levels of specific circulating microRNAs and other molecules related to inflammation and apoptosis, both processes associated with aging. Our results have shown that the systemic levels of miR-21, miR-146a and Fas ligand are lower within the postmenopausal women who are using estrog…

medicine.medical_specialtyCell typemedicine.drug_classMonozygotic twinInflammationBiologyFas ligandInternal medicinemicroRNAmedicinehormonesta1184ta1182ta3141General MedicinemiR-146hormonitFasLCirculating MicroRNAEndocrinologyEstrogenagingsmiR-21medicine.symptomHormoneRNA and Disease
researchProduct